1. Home
  2. HOG vs WVE Comparison

HOG vs WVE Comparison

Compare HOG & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$23.23

Market Cap

2.5B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.25

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOG
WVE
Founded
1903
2012
Country
United States
Singapore
Employees
6400
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
HOG
WVE
Price
$23.23
$7.25
Analyst Decision
Hold
Strong Buy
Analyst Count
7
16
Target Price
$24.00
$29.50
AVG Volume (30 Days)
3.2M
6.4M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
3.14%
N/A
EPS Growth
N/A
N/A
EPS
2.78
N/A
Revenue
$4,473,175,000.00
$3,704,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.79
$85.67
P/E Ratio
$8.22
N/A
Revenue Growth
N/A
149.43
52 Week Low
$17.09
$5.02
52 Week High
$31.25
$21.73

Technical Indicators

Market Signals
Indicator
HOG
WVE
Relative Strength Index (RSI) 63.79 34.60
Support Level $22.75 $6.93
Resistance Level $24.98 $7.67
Average True Range (ATR) 0.82 0.33
MACD 0.09 0.23
Stochastic Oscillator 62.44 47.80

Price Performance

Historical Comparison
HOG
WVE

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: